About this episode

Dr. Avindra Nath discusses the impact of human endogenous retroviruses on human diseases.

In today's throwback to 2022, Dr. Avindra Nath of the NIH reviews research efforts in proteins expressed from human endogenous retroviruses. It is a fascinating discussion of how genome relics may be contributing to insidious human disease.

Topics covered

• human endogenous retroviruses
• disease
• genome relics

Keywords

• NIH
• proteins
• research

More episodes of Talking Biotech with Dr. Kevin Folta

• New Frontiers in Therapeutic Peptides - Dr. Karsten Eastman · April 16, 2026 · 33 min
• Genetic Variation in Vegetative Propagation - Dr. Danelle Seymour · April 1, 2026 · 28 min
• Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh · February 26, 2026 · 47 min
• A Plasmid-Based Cancer Therapy - Dr. Alexander Schneider · February 16, 2026 · 45 min
• Biotech in Beauty Products - Nicholas Brideau · February 1, 2026 · 1h 13m
• Molecular Biology Giants that Left Us In 2025 · January 23, 2026 · 1h 10m

Explore listener stats, chart rankings, contacts and more on the Talking Biotech with Dr. Kevin Folta podcast page.